Keyphrases
Brain Tumor
8%
Clinical Trial Participant
8%
Clinical Trials
100%
Europe
8%
Multiple Complications
8%
Nerve Tumor
8%
Neurofibromatosis
100%
Neurofibromatosis Type 1 (NF-1)
44%
Neurofibromatosis Type 2
16%
Neurofibromatosis Type I
16%
Pearl
8%
Plexiform Neurofibroma
12%
Schwannomatosis
16%
Tumor
12%
Type I Neurofibromatosis
12%
Medicine and Dentistry
Clinical Trial
100%
Disease
10%
Intracranial Tumor
7%
Neoplasm
10%
Nerve Tumor
7%
Neurofibromatosis
100%
Neurofibromatosis Type I
14%
Neurofibromatosis Type II
14%
Plexiform Neurofibroma
14%
Schwannomatosis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Disease
10%
Intracranial Tumor
7%
Neoplasm
10%
Nerve Tumor
7%
Neurofibroma
14%
Neurofibromatosis
100%
Neurofibromatosis Type 1
14%
Neurofibromatosis Type 2
14%